Pseudo-Generic Products and Barriers to Entry in Pharmaceutical Markets

Ying Kong,James R. Seldon
DOI: https://doi.org/10.1023/b:reio.0000040524.32034.04
2004-01-01
Review of Industrial Organization
Abstract:This paper examines incentives for brand-name pharmaceutical producers to market pseudo-generic versions of their own branded products upon the expiry of patent protection. Using a two-stage game model, we determine that under plausible demand and cost conditions, brand-name incumbents can find it profitable to produce pseudo-generics as a means of blocking rivals' entry even when independent firms producing true generics face low entry costs. The model shows that social welfare can be higher when firms use pseudo-generics instead of capacity for entry deterrence as long as substitutability between brand-name and generic products is sufficiently high.
What problem does this paper attempt to address?